Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Long-term impact of acute kidney injury on prognosis in patients with acute myocardial infarction.

Chalikias G, Serif L, Kikas P, Thomaidis A, Stakos D, Makrygiannis D, Chatzikyriakou S, Papoulidis N, Voudris V, Lantzouraki A, Müller M, Arampatzis S, Konstantinides S, Tziakas D.

Int J Cardiol. 2019 May 15;283:48-54. doi: 10.1016/j.ijcard.2019.01.070. Epub 2019 Jan 26.

PMID:
30711262
2.

Abdominal Fat Tissue Echogenicity: A Marker of Morbid Obesity.

Georgiopoulos G, Kontogiannis C, Stakos D, Bakogiannis C, Koliviras A, Kyrkou A, Karapanou L, Benekos K, Augoulea A, Armeni E, Laina A, Stellos K, Lambrinoudaki I, Stamatelopoulos K.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):301-311. doi: 10.1210/jc.2018-01301.

PMID:
30358874
3.

Amyloid-β (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study.

Stamatelopoulos K, Mueller-Hennessen M, Georgiopoulos G, Sachse M, Boeddinghaus J, Sopova K, Gatsiou A, Amrhein C, Biener M, Vafaie M, Athanasouli F, Stakos D, Pateras K, Twerenbold R, Badertscher P, Nestelberger T, Dimmeler S, Katus HA, Zeiher AM, Mueller C, Giannitsis E, Stellos K.

Ann Intern Med. 2018 Jun 19;168(12):855-865. doi: 10.7326/M17-1540. Epub 2018 May 22.

PMID:
29799975
4.

REDD1/Autophagy Pathway Is Associated with Neutrophil-Driven IL-1β Inflammatory Response in Active Ulcerative Colitis.

Angelidou I, Chrysanthopoulou A, Mitsios A, Arelaki S, Arampatzioglou A, Kambas K, Ritis D, Tsironidou V, Moschos I, Dalla V, Stakos D, Kouklakis G, Mitroulis I, Ritis K, Skendros P.

J Immunol. 2018 Jun 15;200(12):3950-3961. doi: 10.4049/jimmunol.1701643. Epub 2018 Apr 30.

5.

Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation.

Chrysanthopoulou A, Kambas K, Stakos D, Mitroulis I, Mitsios A, Vidali V, Angelidou I, Bochenek M, Arelaki S, Arampatzioglou A, Galani IE, Skendros P, Couladouros EA, Konstantinides S, Andreakos E, Schäfer K, Ritis K.

J Pathol. 2017 Sep;243(1):111-122. doi: 10.1002/path.4935. Epub 2017 Aug 7.

PMID:
28678391
6.

The use of theatre in medical education in the emergency cases school: an appealing and widely accessible way of learning.

Keskinis C, Bafitis V, Karailidou P, Pagonidou C, Pantelidis P, Rampotas A, Sideris M, Tsoulfas G, Stakos D.

Perspect Med Educ. 2017 Jun;6(3):199-204. doi: 10.1007/s40037-017-0350-4.

7.

Regulated in development and DNA damage responses 1 (REDD1) links stress with IL-1β-mediated familial Mediterranean fever attack through autophagy-driven neutrophil extracellular traps.

Skendros P, Chrysanthopoulou A, Rousset F, Kambas K, Arampatzioglou A, Mitsios A, Bocly V, Konstantinidis T, Pellet P, Angelidou I, Apostolidou E, Ritis D, Tsironidou V, Galtsidis S, Papagoras C, Stakos D, Kouklakis G, Dalla V, Koffa M, Mitroulis I, Theodorou I, Ritis K.

J Allergy Clin Immunol. 2017 Nov;140(5):1378-1387.e13. doi: 10.1016/j.jaci.2017.02.021. Epub 2017 Mar 23.

PMID:
28342915
8.

The TRACE registry (Trans-Radial Approach in Central and northErn Greece).

Ziakas A, Katranas S, Bobotis G, Mavrogianni AD, Graidis C, Mezilis N, Arampatzis Α, Nikas D, Economou F, Athanasiadis I, Stakos D, Dimopoulos V, Pappa E, Κouparanis A, Petroglou D, Karvounis H.

Hellenic J Cardiol. 2016 Sep - Oct;57(5):323-328. doi: 10.1016/j.hjc.2016.11.004. Epub 2016 Nov 16.

9.

Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.

Stamatelopoulos K, Sibbing D, Rallidis LS, Georgiopoulos G, Stakos D, Braun S, Gatsiou A, Sopova K, Kotakos C, Varounis C, Tellis CC, Kastritis E, Alevizaki M, Tselepis AD, Alexopoulos P, Laske C, Keller T, Kastrati A, Dimmeler S, Zeiher AM, Stellos K.

J Am Coll Cardiol. 2015 Mar 10;65(9):904-16. doi: 10.1016/j.jacc.2014.12.035.

10.

Saddle aortic bifurcation and iliacofemoral arteries tandem embolism in a child with dilated cardiomyopathy.

Georgiadis GS, Charalampidis D, Argyriou C, Antoniou GA, Georgakarakos EI, Argyropoulou PI, Stakos D, Lazarides MK.

Vasa. 2015 Mar;44(2):145-50. doi: 10.1024/0301-1526/a000421. Review. No abstract available.

PMID:
25698393
11.

Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction.

Stakos DA, Kambas K, Konstantinidis T, Mitroulis I, Apostolidou E, Arelaki S, Tsironidou V, Giatromanolaki A, Skendros P, Konstantinides S, Ritis K.

Eur Heart J. 2015 Jun 7;36(22):1405-14. doi: 10.1093/eurheartj/ehv007. Epub 2015 Feb 7.

12.

Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention.

Tziakas D, Chalikias G, Stakos D, Altun A, Sivri N, Yetkin E, Gur M, Stankovic G, Mehmedbegovic Z, Voudris V, Chatzikyriakou S, Garcia-Moll X, Serra A, Passadakis P, Thodis E, Vargemezis V, Kaski JC, Konstantinides S.

Am J Cardiol. 2014 May 1;113(9):1487-93. doi: 10.1016/j.amjcard.2014.02.004. Epub 2014 Feb 12.

PMID:
24630389
13.

In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome.

Alexopoulos D, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Angelidis C, Petousis S, Stakos D, Parissis H, Vavouranakis M, Davlouros P, Goudevenos J, Stefanadis C.

Am Heart J. 2014 Jan;167(1):68-76.e2. doi: 10.1016/j.ahj.2013.10.010. Epub 2013 Oct 22.

PMID:
24332144
14.

Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.

Tzikas S, Schlak D, Sopova K, Gatsiou A, Stakos D, Stamatelopoulos K, Stellos K, Laske C.

J Alzheimers Dis. 2014;39(3):557-64. doi: 10.3233/JAD-131469.

PMID:
24217274
15.

Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children.

Stakos DA, Papaioannou HI, Angelidou I, Mantadakis E, Paraskakis E, Tsigalou C, Chatzimichael A.

J Pediatr Endocrinol Metab. 2014 Mar;27(3-4):221-8. doi: 10.1515/jpem-2013-0195.

PMID:
24150199
16.

Regional and overall aortic function in nondiabetic individuals with insulin resistance and normal glucose tolerance.

Stakos DA, Boudoulas KD, Gaillard TR, Schuster DP, Osei K, Boudoulas H.

J Clin Endocrinol Metab. 2013 Nov;98(11):4457-63. doi: 10.1210/jc.2013-2276. Epub 2013 Sep 24.

17.

Chest pain in patients with arterial hypertension, angiographically normal coronary arteries and stiff aorta: the aortic pain syndrome.

Stakos DA, Tziakas DN, Chalikias G, Mitrousi K, Tsigalou C, Boudoulas H.

Hellenic J Cardiol. 2013 Jan-Feb;54(1):25-31.

18.

Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets.

Stakos DA, Gatsiou A, Stamatelopoulos K, Tselepis AD, Stellos K.

Platelets. 2013;24(8):579-89. doi: 10.3109/09537104.2012.724483. Epub 2012 Sep 20. Review.

PMID:
22994623
19.

Binding of oxidized low-density lipoprotein on circulating platelets is increased in patients with acute coronary syndromes and induces platelet adhesion to vascular wall in vivo--brief report.

Stellos K, Sauter R, Fahrleitner M, Grimm J, Stakos D, Emschermann F, Panagiota V, Gnerlich S, Perk A, Schönberger T, Bigalke B, Langer HF, Gawaz M.

Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):2017-20. doi: 10.1161/ATVBAHA.111.244707. Epub 2012 Jun 14.

PMID:
22701021
20.

Statin-induced immunomodulation alters peripheral invariant natural killer T-cell prevalence in hyperlipidemic patients.

Nakou E, Babageorgakas P, Bouchliou I, Tziakas DN, Miltiades P, Spanoudakis E, Margaritis D, Kotsianidis I, Stakos DA.

Cardiovasc Drugs Ther. 2012 Aug;26(4):293-9. doi: 10.1007/s10557-012-6387-z.

PMID:
22441892
21.

Mechanisms of platelet activation in acute coronary syndromes.

Stakos DA, Tziakas DN, Stellos K.

Curr Vasc Pharmacol. 2012 Sep;10(5):578-88. Review.

PMID:
22338573
22.

Plasma leptin and adiponectin concentrations in healthy, non-obese children.

Papaioannou HI, Stakos DA, Tziakas DN, Chalikias G, Tsigalou C, Kartali S, Mantadakis E, Chatzimichael A.

J Pediatr Endocrinol Metab. 2011;24(5-6):313-8.

PMID:
21823529
23.

Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice.

Tziakas D, Chalikias G, Stakos D, Apostolakis S, Adina T, Kikas P, Alexoudis A, Passadakis P, Thodis E, Vargemezis V, Konstantinides S.

Int J Cardiol. 2013 Feb 10;163(1):46-55. doi: 10.1016/j.ijcard.2011.05.079.

PMID:
21641061
24.

Circulating levels of a biomarker of collagen metabolism are associated with health-related quality of life in patients with chronic heart failure.

Chatzikyriakou SV, Tziakas DN, Chalikias GK, Stakos D, Papazoglou D, Lantzouraki A, Thomaidi A, Boudoulas H, Konstantinides S.

Qual Life Res. 2012 Feb;21(1):143-53. doi: 10.1007/s11136-011-9932-5. Epub 2011 May 20.

PMID:
21598062
25.

Management of acute pulmonary embolism: a contemporary, risk-tailored approach.

Chalikias GK, Tziakas DN, Stakos DA, Konstantinides SV.

Hellenic J Cardiol. 2010 Sep-Oct;51(5):437-50. Review. No abstract available.

26.

Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.

Tziakas DN, Chalikias GK, Stakos D, Chatzikyriakou SV, Papazoglou D, Mitrousi K, Lantzouraki A, Thomaidi A, Boudoulas H, Konstantinides S.

Eur J Prev Cardiol. 2012 Feb;19(1):62-71. doi: 10.1097/HJR.0b013e32833ace76. Epub 2011 Jan 28.

PMID:
20479644
27.

Relation of tricuspid annular displacement and tissue Doppler imaging velocities with duration of weaning in mechanically ventilated patients with acute pulmonary edema.

Papaioannou VE, Stakos DA, Dragoumanis CK, Pneumatikos IA.

BMC Cardiovasc Disord. 2010 May 17;10:20. doi: 10.1186/1471-2261-10-20.

28.

Independent and additive predictive value of total cholesterol content of erythrocyte membranes with regard to coronary artery disease clinical presentation.

Tziakas DN, Chalikias GK, Stakos D, Tentes IK, Papazoglou D, Thomaidi A, Grapsa A, Gioka G, Kaski JC, Boudoulas H.

Int J Cardiol. 2011 Jul 1;150(1):22-7. doi: 10.1016/j.ijcard.2010.02.022. Epub 2010 Mar 12.

PMID:
20223535
29.

Associations between collagen synthesis and degradation and aortic function in arterial hypertension.

Stakos DA, Tziakas DN, Chalikias GK, Mitrousi K, Tsigalou C, Boudoulas H.

Am J Hypertens. 2010 May;23(5):488-94. doi: 10.1038/ajh.2010.2. Epub 2010 Feb 4.

PMID:
20134406
30.

Chronic heart failure patients with high collagen type I degradation marker levels benefit more with ACE-inhibitor therapy.

Chatzikyriakou SV, Tziakas DN, Chalikias GK, Stakos D, Thomaidi A, Mitrousi K, Boudoulas H.

Eur J Pharmacol. 2010 Feb 25;628(1-3):164-70. doi: 10.1016/j.ejphar.2009.11.047. Epub 2009 Dec 1.

PMID:
19958769
31.

Residual platelet reactivity after aspirin administration in pediatric patients.

Wiegand G, Stellos K, Stakos D, Sieverding L, Henkelmann N, Kaulitz R, Hofbeck M, Gawaz M, Rauch R.

Thromb Res. 2010 Jul;126(1):e58-60. doi: 10.1016/j.thromres.2009.09.027. Epub 2009 Nov 26. No abstract available.

PMID:
19944449
32.

The role of red blood cells in the progression and instability of atherosclerotic plaque.

Tziakas DN, Chalikias GK, Stakos D, Boudoulas H.

Int J Cardiol. 2010 Jun 25;142(1):2-7. doi: 10.1016/j.ijcard.2009.10.031. Epub 2009 Nov 10. Review.

PMID:
19906450
33.

Statin use is associated with a significant reduction in cholesterol content of erythrocyte membranes. A novel pleiotropic effect?

Tziakas DN, Chalikias GK, Stakos D, Tentes IK, Thomaidi A, Chatzikyriakou S, Mitrousi K, Kortsaris AX, Kaski JC, Boudoulas H, Konstantinides S.

Cardiovasc Drugs Ther. 2009 Dec;23(6):471-80. doi: 10.1007/s10557-009-6202-7.

PMID:
19838647
34.

A rare case of late right ventricular perforation by a passive-fixation permanent pacemaker lead.

Tziakas D, Alexoudis A, Konstantinou F, Chalikias G, Stakos D, Bougioukas G.

Europace. 2009 Jul;11(7):968-9. doi: 10.1093/europace/eup120. Epub 2009 May 14.

PMID:
19443432
35.

Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome.

Bigalke B, Stellos K, Stakos D, Joos T, Pötz O, Geisler T, Bischofs C, Kremmer E, Krämer BF, Seizer P, May AE, Lindemann S, Gawaz M.

Thromb Haemost. 2009 May;101(5):911-5.

PMID:
19404545
36.

Resolution of symptoms and serum peptides of collagen type I turnover in acute heart failure patients.

Chatzikyriakou SV, Tziakas DN, Chalikias GK, Stakos DA, Thomaidi AK, Mitrousi K, Lantzouraki AE, Kotsiou S, Maltezos E, Boudoulas H.

Acta Cardiol. 2009 Feb;64(1):29-33.

PMID:
19317294
37.

Oxidised low-density lipoprotein and arterial function in beta-thalassemia major.

Stakos DA, Tavridou A, Margaritis D, Tziakas DN, Kotsianidis I, Chalikias GK, Tsatalas K, Bourikas G, Manolopoulos VG, Boudoulas H.

Eur J Haematol. 2009 Jun;82(6):477-83. doi: 10.1111/j.1600-0609.2009.01236.x.

PMID:
19220416
38.

Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.

Stellos K, Bigalke B, Langer H, Geisler T, Schad A, Kögel A, Pfaff F, Stakos D, Seizer P, Müller I, Htun P, Lindemann S, Gawaz M.

Eur Heart J. 2009 Mar;30(5):584-93. doi: 10.1093/eurheartj/ehn566. Epub 2008 Dec 24.

PMID:
19109356
39.

Cholesterol composition of erythrocyte membranes and its association with clinical presentation of coronary artery disease.

Tziakas DN, Chalikias GK, Stakos D, Tentes IK, Chatzikyriakou SV, Mitrousi K, Kortsaris AX, Boudoulas H, Kaski JC.

Coron Artery Dis. 2008 Dec;19(8):583-90. doi: 10.1097/MCA.0b013e328313819b.

PMID:
19005293
40.

Serum levels of collagen type-I degradation markers are associated with vascular stiffness in chronic heart failure patients.

Chatzikyriakou SV, Tziakas DN, Chalikias GK, Stakos DA, Thomaidi AK, Mitrousi K, Lantzouraki AE, Kotsiou S, Maltezos E, Boudoulas H.

Eur J Heart Fail. 2008 Dec;10(12):1181-5. doi: 10.1016/j.ejheart.2008.09.007. Epub 2008 Oct 11.

41.

Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome.

Tziakas DN, Chalikias GK, Tentes IK, Stakos D, Chatzikyriakou SV, Mitrousi K, Kortsaris AX, Kaski JC, Boudoulas H.

Eur Heart J. 2008 Nov;29(22):2713-22. doi: 10.1093/eurheartj/ehn382. Epub 2008 Sep 2.

PMID:
18765457
42.

Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation.

Tziakas DN, Chalikias GK, Stakos DA, Papanas N, Chatzikyriakou SV, Mitrousi K, Maltezos E, Boudoulas H.

Am J Cardiol. 2008 Jan 15;101(2):199-202. doi: 10.1016/j.amjcard.2007.07.063.

PMID:
18178406
43.

Effect of angiotensin-converting enzyme insertion/deletion genotype on collagen type I synthesis and degradation in patients with atrial fibrillation and arterial hypertension.

Tziakas DN, Chalikias GK, Stakos DA, Papazoglou D, Papanas N, Papatheodorou K, Chatzikyriakou SV, Kotsiou S, Maltezos E, Boudoulas H.

Expert Opin Pharmacother. 2007 Oct;8(14):2225-34.

PMID:
17927479
44.

Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance.

Stakos DA, Schuster DP, Sparks EA, Meis SB, Wooley CF, Osei K, Boudoulas H.

Eur J Endocrinol. 2007 Jul;157(1):63-8.

PMID:
17609403
45.

Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation.

Tziakas DN, Chalikias GK, Papanas N, Stakos DA, Chatzikyriakou SV, Maltezos E.

Europace. 2007 Aug;9(8):589-96. Epub 2007 May 7.

PMID:
17485436
46.

Leukocyte activation after coronary stenting in patients during the subacute phase of a previous ST-elevation myocardial infarction.

Stakos DA, Kotsianidis I, Tziakas DN, Spanoudakis E, Chalikias G, Bourikas G, Katsaris G, Boudoulas H.

Coron Artery Dis. 2007 Mar;18(2):105-10.

PMID:
17301601
47.

Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome.

Chalikias GK, Tziakas DN, Kaski JC, Kekes A, Hatzinikolaou EI, Stakos DA, Tentes IK, Kortsaris AX, Hatseras DI.

Int J Cardiol. 2007 May 2;117(3):333-9. Epub 2006 Jul 20.

PMID:
16859776
48.

Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach.

Tziakas DN, Chalikias GK, Kaski JC, Kekes A, Hatzinikolaou EI, Stakos DA, Tentes IK, Kortsaris AX, Hatseras DI.

Atherosclerosis. 2007 Jul;193(1):196-203. Epub 2006 Jul 20.

PMID:
16857204
49.

Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.

Hatzinikolaou-Kotsakou E, Tziakas D, Hotidis A, Stakos D, Floros D, Papanas N, Chalikias G, Maltezos E, Hatseras DI.

Am J Cardiol. 2006 Mar 1;97(5):659-61. Epub 2006 Jan 6.

PMID:
16490433
50.

Levosimendan use reduces matrix metalloproteinase-2 in patients with decompensated heart failure.

Tziakas DN, Chalikias GK, Hatzinikolaou HI, Stakos DA, Papanas N, Tentes IK, Kortsaris AX, Maltezos E, Hatseras DI, Kaski JC.

Cardiovasc Drugs Ther. 2005 Dec;19(6):399-402.

PMID:
16435069

Supplemental Content

Loading ...
Support Center